Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice

Background: Gaps in current evidence and guidance leave clinicians with unanswered questions on the use of cladribine tablets for the treatment of multiple sclerosis (MS) in the era of the COVID-19 pandemic, in particular relating to COVID-19 vaccination. Objective: We describe a consensus-based pro...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H. Hua, Celia Oreja-Guevara, Daniel Selchen, Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SAGE Publishing 2021-12-01
Colecção:	Therapeutic Advances in Neurological Disorders
Acesso em linha:	https://doi.org/10.1177/17562864211058298
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!